Open AccessAntibiotics and Adverse Events in Patients with Pancreatic Cancer Treated with Gemcitabine: Looking for Novel Clinical and Preclinical Insights
Author(s) -
El Hassouni Btissame,
Gregori Alessandro,
Puik Jisce R.,
Deng Dongmei,
Kazemier Geert,
Giovannetti Elisa
Publication year - 2021
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1002/onco.13606
Subject(s) - medicine , gemcitabine , adverse effect , pancreatic cancer , antibiotics , intensive care medicine , oncology , cancer , microbiology and biotechnology , biology
This letter to the editor remarks on a recently published article reporting on gemcitabine‐related adverse events associated with antibacterial use, focusing on key points for further consideration.